MTOR and neoplasm: Histological type, tumor grade, PTEN loss and the expression of molecular markers of the PI3K/Akt/mTOR pathway (mTOR, phosphorylated AKT (pAKT) and phosphorylated S6 (pS6)) did not correlate with the clinical outcome.